Article Versions Notes

Purkey LR, Mehedincu S, Irvine C, Akdag R, Little M, Kothmann WW, Rus K, Greenberg E, Shady N, DeCicco-Skinner K. Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2^−/− Mice. Cancers. 2025; 17(20):3362. https://doi.org/10.3390/cancers17203362

Purkey, Laura R., Stefania Mehedincu, Charles Irvine, Raelyn Akdag, Megan Little, W. Wade Kothmann, Katharine Rus, Erin Greenberg, Neil Shady, and Kathleen DeCicco-Skinner. 2025. "Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2^−/− Mice" Cancers 17, no. 20: 3362. https://doi.org/10.3390/cancers17203362

Purkey, L. R., Mehedincu, S., Irvine, C., Akdag, R., Little, M., Kothmann, W. W., Rus, K., Greenberg, E., Shady, N., & DeCicco-Skinner, K. (2025). Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2^−/− Mice. Cancers, 17(20), 3362. https://doi.org/10.3390/cancers17203362